Cornerstone Therapeutics Inc. (Nasdaq: CRTX) announced a strategic transaction with Chiesi Farmaceutici SpA, a leading European pharmaceutical company headquartered ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE